USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
Despite a considerable advance made in epileptology, resistant epilepsies are about 30% among all epilepsy types particularly in patients with focal seizures. In these cases, there is hope for the success of neurosurgical treatment and the synthesis of new antiepileptic drugs (AEDs). The authors pro...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-04-01
|
Series: | Russkij Žurnal Detskoj Nevrologii |
Subjects: | |
Online Access: | https://rjdn.abvpress.ru/jour/article/view/29 |
id |
doaj-0411fc63e4de42aba66c40b43926af44 |
---|---|
record_format |
Article |
spelling |
doaj-0411fc63e4de42aba66c40b43926af442021-07-29T08:20:40ZrusABV-pressRusskij Žurnal Detskoj Nevrologii2073-88032412-91782015-04-0193364210.17650/2073-8803-2014-9-3-36-4223USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATUREO. A. Pylaeva0K. Yu. Mukhin1Svt. Luka’s Institute of Child Neurology and Epilepsy, MoscowSvt. Luka’s Institute of Child Neurology and Epilepsy, MoscowDespite a considerable advance made in epileptology, resistant epilepsies are about 30% among all epilepsy types particularly in patients with focal seizures. In these cases, there is hope for the success of neurosurgical treatment and the synthesis of new antiepileptic drugs (AEDs). The authors provide a review of the literature dealing the new AED perampanel (Fycompa) and consider its mechanism of action, pharmacokinetics, clinical and postmarketing trials of its efficacy, tolerability, and safety. Based on the data available in the literature, it may be concluded that parampanel is a promising highly effective and well tolerated AED to treat partial and secondary generalized seizures.https://rjdn.abvpress.ru/jour/article/view/29epilepsyantiepileptic drugsperampanel (fycompa)efficacytolerability |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
O. A. Pylaeva K. Yu. Mukhin |
spellingShingle |
O. A. Pylaeva K. Yu. Mukhin USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE Russkij Žurnal Detskoj Nevrologii epilepsy antiepileptic drugs perampanel (fycompa) efficacy tolerability |
author_facet |
O. A. Pylaeva K. Yu. Mukhin |
author_sort |
O. A. Pylaeva |
title |
USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE |
title_short |
USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE |
title_full |
USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE |
title_fullStr |
USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE |
title_full_unstemmed |
USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE |
title_sort |
use of the new antiepileptic drug perampanel (fycompa) in the treatment of epilepsy: a review of foreign literature |
publisher |
ABV-press |
series |
Russkij Žurnal Detskoj Nevrologii |
issn |
2073-8803 2412-9178 |
publishDate |
2015-04-01 |
description |
Despite a considerable advance made in epileptology, resistant epilepsies are about 30% among all epilepsy types particularly in patients with focal seizures. In these cases, there is hope for the success of neurosurgical treatment and the synthesis of new antiepileptic drugs (AEDs). The authors provide a review of the literature dealing the new AED perampanel (Fycompa) and consider its mechanism of action, pharmacokinetics, clinical and postmarketing trials of its efficacy, tolerability, and safety. Based on the data available in the literature, it may be concluded that parampanel is a promising highly effective and well tolerated AED to treat partial and secondary generalized seizures. |
topic |
epilepsy antiepileptic drugs perampanel (fycompa) efficacy tolerability |
url |
https://rjdn.abvpress.ru/jour/article/view/29 |
work_keys_str_mv |
AT oapylaeva useofthenewantiepilepticdrugperampanelfycompainthetreatmentofepilepsyareviewofforeignliterature AT kyumukhin useofthenewantiepilepticdrugperampanelfycompainthetreatmentofepilepsyareviewofforeignliterature |
_version_ |
1721256422807699456 |